Cargando…

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice

Oral rotenone has been proposed as a model for Parkinson’s disease (PD) in mice. To establish the model in our lab and study complex behavior we followed a published treatment regimen. C57BL/6 mice received 30 mg/kg body weight of rotenone once daily via oral administration for 4 and 8 weeks. Motor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niederberger, Ellen, Wilken-Schmitz, Annett, Manderscheid, Christine, Schreiber, Yannick, Gurke, Robert, Tegeder, Irmgard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604506/ https://www.ncbi.nlm.nih.gov/pubmed/36293513 http://dx.doi.org/10.3390/ijms232012658

Ejemplares similares

Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in mice
por: Vogel, Alexandra, et al.
Publicado: (2020)

Increased Fat Taste Preference in Progranulin-Deficient Mice
por: Schumann, Lana, et al.
Publicado: (2021)

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice
por: Schmitz, Katja, et al.
Publicado: (2021)

Progranulin deficiency confers resistance to autoimmune encephalomyelitis in mice
por: Schmitz, Katja, et al.
Publicado: (2019)

Trehalose Reduces Nerve Injury Induced Nociception in Mice but Negatively Affects Alertness
por: Kraft, Vanessa, et al.
Publicado: (2021)

Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
por: Pan-Montojo, Francisco, et al.
Publicado: (2010)

Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus
por: Hardt, Stefanie, et al.
Publicado: (2018)

Mast cell tetrahydrobiopterin contributes to itch in mice
por: Zschiebsch, Katja, et al.
Publicado: (2018)

Reduced exploratory behavior in neuronal nucleoredoxin knockout mice
por: Tran, Bao Ngoc, et al.
Publicado: (2021)

Phosphatidylethanolamine Deficiency and Triglyceride Overload in Perilesional Cortex Contribute to Non-Goal-Directed Hyperactivity after Traumatic Brain Injury in Mice
por: Hahnefeld, Lisa, et al.
Publicado: (2022)

Failure of Diphtheria Toxin Model to Induce Parkinson-Like Behavior in Mice
por: Valek, Lucie, et al.
Publicado: (2021)

Sphingolipid and Endocannabinoid Profiles in Adult Attention Deficit Hyperactivity Disorder
por: Brunkhorst-Kanaan, Nathalie, et al.
Publicado: (2021)

AGMO Inhibitor Reduces 3T3-L1 Adipogenesis
por: Fischer, Caroline, et al.
Publicado: (2021)

The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease
por: Landau, Regev, et al.
Publicado: (2022)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Repetitive and compulsive behavior after Early-Life-Pain associated with reduced long-chain sphingolipid species
por: Vogel, Alexandra, et al.
Publicado: (2023)

Inter-strain differences of serotonergic inhibitory pain control in inbred mice
por: Wijnvoord, Nina, et al.
Publicado: (2010)

Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020)

Sensory neuropathy and nociception in rodent models of Parkinson's disease
por: Valek, Lucie, et al.
Publicado: (2019)

Progranulin contributes to endogenous mechanisms of pain defense after nerve injury in mice
por: Lim, Hee-Young, et al.
Publicado: (2012)

ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers
por: Mooz, Juliane, et al.
Publicado: (2022)

R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
por: Schmitz, Katja, et al.
Publicado: (2014)

Anti-inflammatory and Anti-oxidant Activity of Hidrox(®) in Rotenone-Induced Parkinson’s Disease in Mice
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Nerve Injury Evoked Loss of Latexin Expression in Spinal Cord Neurons Contributes to the Development of Neuropathic Pain
por: Kühlein, Hilmar Nils, et al.
Publicado: (2011)

Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review
por: Schmitz, Katja, et al.
Publicado: (2017)

Inhibition of HDAC Enzymes Contributes to Differential Expression of Pro-Inflammatory Proteins in the TLR-4 Signaling Cascade
por: Weiss, Ulrike, et al.
Publicado: (2020)

Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease
por: Arnhold, Mike, et al.
Publicado: (2016)

The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2020)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Learning and memory with neuropathic pain: impact of old age and progranulin deficiency
por: Albuquerque, Boris, et al.
Publicado: (2013)

Expression and regulation of redoxins at nociceptive signaling sites after sciatic nerve injury in mice
por: Valek, Lucie, et al.
Publicado: (2015)

Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease
por: Yang, Xiaodong, et al.
Publicado: (2018)

Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson's Disease
por: Schaffernicht, Gabriela, et al.
Publicado: (2021)

Time Course of Neurobehavioral Disruptions and Regional Brain Metabolism Changes in the Rotenone Mice Model of Parkinson’s Disease
por: Troshev, Dmitry, et al.
Publicado: (2022)

Prevention of age-associated neuronal hyperexcitability with improved learning and attention upon knockout or antagonism of LPAR2
por: Fischer, Caroline, et al.
Publicado: (2020)

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
por: Liu, Hui-Fang, et al.
Publicado: (2017)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e754t2cmt3kqko0v0064gv638d